La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Cooper Companies Résultats passés
Passé contrôle des critères 4/6
Les bénéfices de Cooper Companies ont diminué à un taux annuel moyen de -8.9%, tandis que le secteur Medical Equipment a vu ses bénéfices augmenter de en à 11.2% par an. Les revenus ont augmenté de en à un taux moyen de 8.9% par an. Le rendement des capitaux propres de Cooper Companies est 4.4% et ses marges nettes sont de 9.1%.
Informations clés
-8.9%
Taux de croissance des bénéfices
-8.9%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 8.9% |
Taux de croissance des recettes | 8.9% |
Rendement des fonds propres | 4.4% |
Marge nette | 9.1% |
Prochaine mise à jour des résultats | 28 Aug 2024 |
Mises à jour récentes des performances passées
Recent updates
Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03The Cooper Companies Non-GAAP EPS of $3.19 misses by $0.04, revenue of $843.4M beats by $13.18M
Aug 31Is Now The Time To Look At Buying The Cooper Companies, Inc. (NYSE:COO)?
Aug 30Cooper Companies: The Perfect Harbor For A Perfect Storm
Aug 18Cooper Companies (NYSE:COO) Seems To Use Debt Quite Sensibly
Aug 03Ventilation des recettes et des dépenses
Comment Cooper Companies gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Apr 24 | 3,732 | 340 | 1,521 | 152 |
31 Jan 24 | 3,666 | 291 | 1,580 | 145 |
31 Oct 23 | 3,593 | 294 | 1,530 | 137 |
31 Jul 23 | 3,514 | 275 | 1,488 | 130 |
30 Apr 23 | 3,427 | 288 | 1,467 | 122 |
31 Jan 23 | 3,380 | 375 | 1,350 | 116 |
31 Oct 22 | 3,308 | 386 | 1,338 | 110 |
31 Jul 22 | 3,219 | 431 | 1,297 | 107 |
30 Apr 22 | 3,139 | 948 | 1,238 | 103 |
31 Jan 22 | 3,029 | 939 | 1,205 | 98 |
31 Oct 21 | 2,923 | 2,945 | 1,142 | 93 |
31 Jul 21 | 2,845 | 2,916 | 1,122 | 93 |
30 Apr 21 | 2,660 | 2,355 | 1,054 | 90 |
31 Jan 21 | 2,465 | 2,249 | 997 | 93 |
31 Oct 20 | 2,431 | 238 | 991 | 93 |
31 Jul 20 | 2,441 | 278 | 937 | 91 |
30 Apr 20 | 2,542 | 343 | 972 | 91 |
31 Jan 20 | 2,672 | 454 | 981 | 88 |
31 Oct 19 | 2,653 | 467 | 993 | 87 |
31 Jul 19 | 2,613 | 446 | 981 | 86 |
30 Apr 19 | 2,594 | 427 | 957 | 87 |
31 Jan 19 | 2,571 | 366 | 944 | 87 |
31 Oct 18 | 2,533 | 140 | 973 | 85 |
31 Jul 18 | 2,443 | 128 | 907 | 81 |
30 Apr 18 | 2,339 | 131 | 864 | 76 |
31 Jan 18 | 2,230 | 175 | 823 | 72 |
31 Oct 17 | 2,139 | 373 | 799 | 69 |
31 Jul 17 | 2,096 | 345 | 756 | 68 |
30 Apr 17 | 2,055 | 329 | 739 | 67 |
31 Jan 17 | 2,016 | 298 | 726 | 67 |
31 Oct 16 | 1,967 | 274 | 711 | 65 |
31 Jul 16 | 1,904 | 250 | 679 | 63 |
30 Apr 16 | 1,851 | 207 | 666 | 64 |
31 Jan 16 | 1,801 | 194 | 656 | 64 |
31 Oct 15 | 1,797 | 204 | 661 | 65 |
31 Jul 15 | 1,810 | 198 | 659 | 67 |
30 Apr 15 | 1,780 | 241 | 655 | 66 |
31 Jan 15 | 1,758 | 259 | 648 | 66 |
31 Oct 14 | 1,718 | 270 | 639 | 66 |
31 Jul 14 | 1,661 | 296 | 632 | 64 |
30 Apr 14 | 1,640 | 297 | 623 | 63 |
31 Jan 14 | 1,611 | 293 | 618 | 61 |
31 Oct 13 | 1,588 | 296 | 610 | 59 |
Des revenus de qualité: COO a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de COO (9.1%) sont supérieures à celles de l'année dernière (8.4%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de COO ont diminué de 8.9% par an au cours des 5 dernières années.
Accélération de la croissance: La croissance des bénéfices de COO au cours de l'année écoulée ( 17.9% ) dépasse sa moyenne sur 5 ans ( -8.9% par an).
Bénéfices par rapport au secteur d'activité: La croissance des bénéfices COO au cours de l'année écoulée ( 17.9% ) a dépassé celle du secteur Medical Equipment 5.5%.
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de COO ( 4.4% ) est considéré comme faible.